Rachel L. Henson

Alzheimer’s Disease Neuroimaging Initiative

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 25 papers. Top paper: “Baseline levels and longitudinal rates of change in plasma Aβ42/40 among self-identified Black/African American and White individuals”.

Baseline levels and longitudinal rates of change in plasma Aβ42/40 among self-identified Black/African American and White individuals

Research Square(2024)10.21203/rs.3.rs-3783571/v1

N/A

0.360DataRank · unranked

10 citations

Suzanne E. Schindler, Jingqin Luo, John C. Morris, Randall J. Bateman, David M. Holtzman +16 more

Lumipulse-Measured Cerebrospinal Fluid Biomarkers for the Early Detection of Alzheimer Disease

Neurology(2024)10.1212/wnl.0000000000209866

N/A

0.345DataRank · unranked

9 citations

Jenna R. Groh, Kaj Blennow, Henrik Zetterberg, Yorghos Tripodis, Brett Martin +14 more

Deep learning enhanced ALPS reveals genetic and environmental factors of brain glymphatic function

eBioMedicine(2026)10.1016/j.ebiom.2026.106133

N/A

0.208DataRank · unranked

3 citations

Hao Wu, Wenbiao Xian, Yifan Zheng, Wenxuan Du, Xinyi Chen +1916 more

African Americans Have Differences in CSF Soluble TREM2 and Associated Genetic Variants

Neurology Genetics(2021)10.1212/nxg.0000000000000571

N/A

0DataRank · unranked

56 citations

Carlos Cruchaga, Amulya Joseph, Lena McCue, Fabiana Farias, Consuelo H. Wilkins +13 more

Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light

Neurology(2022)10.1212/wnl.0000000000200358

N/A

0DataRank · unranked

148 citations

Thomas K. Karikari, Nicholas J. Ashton, Rachel L. Henson, Kevin E. Yarasheski, Tim West +16 more

Comparative Analysis of Alzheimer’s Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach

Journal of Alzheimer s Disease(2022)10.3233/jad-220399

N/A

0DataRank · unranked

70 citations

Duber Gomez‐Fonseca, Lihua Wang, Anh Do, Daniel Western, Ignacio Álvarez +21 more

Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study

The Lancet Neurology(2022)10.1016/s1474-4422(22)00408-2

N/A

0DataRank · unranked

56 citations

Brian A. Gordon, Julie K. Wisch, Shaney Flores, Rachel L. Henson, Omar H. Butt +95 more

A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer’s disease

Brain Communications(2022)10.1093/braincomms/fcac045

N/A

0DataRank · unranked

55 citations

Yingxin He, Nicolas R. Barthélemy, Hong Jiang, Yan Li, Ethan Park +5 more

Proteomic clusters underlie heterogeneity in preclinical Alzheimer’s disease progression

Brain(2022)10.1093/brain/awac484

N/A

0DataRank · unranked

11 citations

Omar H. Butt, Brian A. Gordon, Suzanne E. Schindler, Anne M. Fagan, Rachel L. Henson +8 more

CSF tau phosphorylation at T217 and T205 are improved biomarkers of amyloid and tau pathology in Alzheimer disease

Research Square(2022)10.21203/rs.3.rs-2175929/v1

N/A

0DataRank · unranked

2 citations

Benjamin Saef, Yan Li, Brian A. Gordon, Yingxin He, Kanta Horie +14 more

CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease

Nature Aging(2023)10.1038/s43587-023-00380-7

N/A

0DataRank · unranked

153 citations

Benjamin Saef, Yan Li, Brian A. Gordon, Yingxin He, Kanta Horie +14 more

Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40

Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring(2023)10.1002/dad2.12405

N/A

0DataRank · unranked

30 citations

Brian A. Gordon, Anna H. Boerwinkle, Patrick H. Luckett, James G. Bollinger, Vitaliy Ovod +12 more

Relationships of Cognitive Measures with Cerebrospinal Fluid but Not Imaging Biomarkers of Alzheimer Disease Vary between Black and White Individuals

Annals of Neurology(2023)10.1002/ana.26838

N/A

0DataRank · unranked

19 citations

Ruijin Lu, Suzanne E. Schindler, Quoc Bui, James J. Lah, David A. Wolk +31 more

Diagnostic Utility of Cerebrospinal Fluid Biomarkers in Patients with Rapidly Progressive Dementia

Annals of Neurology(2023)10.1002/ana.26822

N/A

0DataRank · unranked

16 citations

Philip W. Tipton, Yuka A. Martens, Matthew R. Brier, Nihal Satyadev, Steven Dunham +11 more

Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset

Annals of Neurology(2024)10.1002/ana.26891

N/A

0DataRank · unranked

88 citations

Daniel Yen, Rachel Hendrix, Brian A. Gordon, Sibonginkhosi L. Dlamini, Nicolas R. Barthélemy +17 more

CSF biomarkers of immune activation and Alzheimer’s disease for predicting cognitive impairment risk in the elderly

Science Advances(2024)10.1126/sciadv.adk3674

N/A

0DataRank · unranked

33 citations

Launia J. White, Rachel Hendrix, Jason D. Ulrich, Rachel L. Henson, William D. Knight +19 more

Cerebrovascular disease is associated with Alzheimer’s plasma biomarker concentrations in adults with Down syndrome

Brain Communications(2024)10.1093/braincomms/fcae331

N/A

0DataRank · unranked

29 citations

Patrick J. Lao, Mohamad J. Alshikho, Olivia M. Ericsson, Batool Rizvi, Melissa Petersen +70 more

Baseline levels and longitudinal changes in plasma Aβ42/40 among Black and white individuals

Nature Communications(2024)10.1038/s41467-024-49859-w

N/A

0DataRank · unranked

20 citations

Jingqin Luo, David A. Wolk, Leslie M. Shaw, Erik D. Roberson, Charles Murchison +16 more

Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer’s disease

Brain Communications(2024)10.1093/braincomms/fcae081

N/A

0DataRank · unranked

23 citations

Patrick H. Luckett, Nicolas R. Barthélemy, Diana A. Hobbs, Charles D. Chen, James Bollinger +17 more

Predicting continuous amyloid PET values with CSF tau phosphorylation occupancies

Alzheimer s & Dementia(2024)10.1002/alz.14132

N/A

0DataRank · unranked

8 citations

Brian A. Gordon, Nicolas R. Barthélemy, Kanta Horie, Rachel L. Henson, Yingxin He +7 more

Cognition Mediates the Association Between Cerebrospinal Fluid Biomarkers of Amyloid and P-Tau and Neuropsychiatric Symptoms

Journal of Alzheimer s Disease(2024)10.3233/jad-240125

N/A

0DataRank · unranked

6 citations

Michael J. Walsh, Landon Hurley, Jenna R. Groh, Kaj Blennow, Henrik Zetterberg +18 more

The effects of mosaicism on biological and clinical markers of Alzheimer's disease in adults with Down syndrome

EBioMedicine(2024)10.1016/j.ebiom.2024.105433

N/A

0DataRank · unranked

6 citations

Lam‐Ha T. Dang, Alice Lee, Sharon J. Krinsky‐McHale, Deborah Pang, Lisa Melilli +72 more

Correlating hippocampal and amygdala volumes with neuropathological burden in Down syndrome and Alzheimer’s disease and related neurodegenerative pathologies using 7T postmortem MRI

Journal of Neuropathology & Experimental Neurology(2025)10.1093/jnen/nlaf010

N/A

0DataRank · unranked

6 citations

Jinghang Li, Jacob Berardinelli, Hecheng Jin, Tales Santini, Jaehoon Noh +69 more

Efficient Site-Specific Prokaryotic and Eukaryotic Incorporation of Halotyrosine Amino Acids into Proteins

ACS Chemical Biology(2020)10.1021/acschembio.9b01026

N/A

0DataRank · unranked

23 citations

Xiaodong Gu, Richard B. Cooley, Joseph J. Porter, Rachel L. Henson, Taylor S. Willi +4 more

Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study

The Lancet Neurology(2021)10.1016/s1474-4422(21)00139-3

N/A

0DataRank · unranked

71 citations

Rachel L. Henson, Yan Li, Anna H. Boerwinkle, Chengjie Xiong, Randall J. Bateman +29 more